[1]
“Swiss experience of atezolizumab for platinum-pretreated urinary tract carcinoma: the SAUL study in real-world practice”, Swiss Med Wkly, vol. 150, no. 1920, p. w20223, May 2020, doi: 10.4414/smw.2020.20223.